Fort LP’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-2,881
Closed -$226K 457
2019
Q4
$226K Sell
2,881
-2,843
-50% -$209K 0.04% 280
2019
Q3
$391K Sell
5,724
-1,381
-19% -$92.7K 0.07% 266
2019
Q2
$564K Sell
7,105
-1,992
-22% -$158K 0.11% 235
2019
Q1
$763K Sell
9,097
-49,365
-84% -$5.15M 0.15% 214
2018
Q4
$6.88M Sell
58,462
-45,396
-44% -$5.25M 1.62% 7
2018
Q3
$12.5M Buy
103,858
+2,046
+2% +$254K 2.8% 6
2018
Q2
$11.7M Sell
101,812
-1,233
-1% -$135K 2.78% 14
2018
Q1
$8.85M Buy
103,045
+50,856
+97% +$3.94M 2.13% 17
2017
Q4
$3.87M Buy
52,189
+51,474
+7,199% +$3.44M 0.91% 28
2017
Q3
$41K Buy
+715
New +$42.2K 0.01% 42

Other funds holding USNA

Fort LP's USNA Position: Q1 2020 in Review

Fort LP sold out of Usana Health Sciences (USNA) in Q1 2020, closing a stake of 2,881 shares — an estimated $226K sold.

Fort LP first reported a position in USNA in Q3 2017 and held it in 10 quarters. The position peaked at $12.5M in Q3 2018. 169 funds tracked by Wall St. Rank hold USNA as of Q1 2020.

  • Fort LP reported no remaining Usana Health Sciences position as of Q1 2020 after selling out during the quarter.
  • Fort LP sold 2,881 Usana Health Sciences shares in Q1 2020, an estimated $226K.
  • Fort LP first reported a position in Usana Health Sciences in Q3 2017 and held it in 10 quarters.
  • Fort LP's Usana Health Sciences position peaked at $12.5M in Q3 2018.
  • 169 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2020.

Based on Fort LP's 13F filing for Q1 2020, filed 14 May 2020.